comprehensive -WSS

comprehensive

author：comprehensive 2025-09-27 23:03:40 - browse：35

John Thune raises one hand while speaking to the press at the Capitol 2024 — politics coverage from STAT — Sen. John Thune is one of a group of lawmakers that is working on 340B reform legislation. BRENDAN SMIALOWSKI/AFP via Getty Images

WASHINGTON — A bipartisan group of senators released a draft of legislation to resolve controversial disputes in the 340B drug discount program, according to documents obtained by STAT.

The drug discount program, which was designed to support providers that serve low-income patients, has been increasingly contentious as it’s grown in recent years. The draft legislation makes a number of changes to address some of the most controversial points, including its rules over so-called “contract pharmacies” and which subsidiaries can qualify for discounts.

The draft would also require more oversight, and it would give the Health Resources and Services Administration more money to do it with a new user fee program. Providers would pay HRSA up to 0.1% of the savings it receives from the program.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Cano Health’s bankruptcy is a warning for Medicare Advantage

WSS

Gene therapy for Afghan refugees’ infant will be fully covered

Why doctors need education on FDA device approval process

Francis Collins on trust in science and how Covid communications failed

Why doctors need education on FDA device approval process

Why CTE doesn’t keep Americans from enjoying the Super Bowl

How digital therapeutics firms are pivoting after Pear's bankruptcy

entertainment

comprehensive

entertainment

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Prior authorization will have to move faster under new Biden rule

Cancer drug shortages should be causing more outrage

Readout LOUD: Venture capital, Gilead, and more M&A

Malaria cases in Florida and Texas: Here’s what you need to know

FDA clears AI tool for detecting skin cancer

23andMe had bad news about my health. I wish a person had delivered it

The tragedy of Johnson & Johnson’s Covid vaccine

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

FDA clears AI tool for detecting skin cancer

explore

Francis Collins on trust in science and how Covid communications failed

NIH director takes cautious approach to Biden drug pricing priority

Cano Health’s bankruptcy is a warning for Medicare Advantage

Top private equity targets in 2023: cardiology, clinical trials, lasers

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Humana cuts profit projections as Medicare Advantage costs soar

focus

knowledge

leisure time

explore